NEAT1 overexpression promotes EMT and invasion in breast cancer, renal cell carcinoma, renal cell carcinoma, hepatoblastoma and nasopharyngeal carcinoma (Lu et al., 2016; Fu et al., 2017; Liu et al., 2017a; Li W. et al., 2017; Ning et al., 2017; Zhang et al., 2017; Zheng et al., 2018). Here, NEAT1 is linked to nasopharyngeal carcinoma.